Pathstone Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,126
Closed -$213K 2303
2024
Q1
$213K Buy
+3,126
New +$213K ﹤0.01% 2103